Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Observational Study With Real-World Data to Assess Demographic and Clinicopathological Profiles, and Management of Breast Cancer Patients With Positive, Low or Negative Expression of HER2 in Spain

NCT05217381 is registered in ClinicalTrials.gov with MedSIR as lead sponsor.

NCT NCT05217381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Observational Study With Real-World Data to Assess Demographic and Clinicopathological Profiles, and Management of Breast Cancer Patients With Positive, Low or Negative Expression of HER2 in Spain
Lead sponsor
MedSIR
Phase
Observational
Overall status
Completed
Start date
February 22, 2022
Completion date
September 20, 2023
Enrollment
18,533 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

early breast cancer, locally advanced breast cancer, metastatic breast cancer